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Abstract
Tuberculosis (TB) remains a significant public health problem worldwide, but the ecology of
the prevalent mycobacterial strains, and their transmission, can vary depending on country
and region. Chile is a country with low incidence of TB, that has a geographically isolated lo-
cation in relation to the rest of South American countries due to the Andes Mountains, but
recent migration from neighboring countries has changed this situation. We aimed to as-
sess the genotypic diversity ofMycobacterium tuberculosis complex (MTBC) strains in
Santiago, Chile, and compare with reports from other Latin-American countries. We ana-
lyzed MTBC isolates from pulmonary tuberculosis cases collected between years 2008 and
2013 in Central Santiago, using two genotyping methods: spoligotyping and 12-loci myco-
bacterial interspersed repetitive unit-variable number of tandem repeats (MIRU-VNTRs).
Data obtained were analyzed and compared to the SITVIT2 database. Mean age of the pa-
tients was 47.5 years and 61% were male; 11.6% were migrants. Of 103 strains (1 isolate/
patient) included, there were 56 distinct spoligotype patterns. Of these, 16 strains (15.5%)
corresponded to orphan strains in the SITVIT2 database, not previously reported. Latin
American and Mediterranean (LAM) (34%) and T (33%) lineages were the most prevalent
strains, followed by Haarlem lineage (16.5%). Beijing family was scarcely represented with
only two cases (1.9%), one of them isolated from a Peruvian migrant. The most frequent
clustered spoligotypes were SIT33/LAM3 (10.7%), SIT53/T1 (8.7%), SIT50/H3 (7.8%), and
SIT37/T3 (6.8%). We conclude that LAM and T genotypes are the most prevalent geno-
types of MTBC in Santiago, Chile, and together correspond to almost two thirds of analyzed
strains, which is similar to strain distribution reported from other countries of Latin America.
Nevertheless, the high proportion of SIT37/T3, which was rarely found in other Latin
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American countries, may underline a specific history or demographics of Chile related to
probable human migrations and evolutions.
Introduction
Tuberculosis (TB) is an infectious disease that remains present broadly despite intense global
efforts for its control and elimination. In 2012, there were 8.6 million incident cases and more
than 1.3 million deaths from tuberculosis worldwide [1]. Its causative agent,Mycobacterium
tuberculosis, has accompanied human beings for thousands of years and, despite this very long
period of coexistence,M. tuberculosis has remained among the most extreme examples of bac-
terial genetic homogeneity, with divergence rarely higher than 0.5 single nucleotide polymor-
phisms per genome per year [2][3]. Accordingly, for decades scientists have believed that
different clinical or epidemiological outcomes of this infection in humans were largely related
to host susceptibility and environmental factors, and not to the bacteria. However, this view
has been challenged from the mid 2000’s, when comparative genomic and molecular epidemio-
logical tools identified large sequence polymorphisms (LSPs) that allowed to differentiate
M. tuberculosis into main six main lineages that defined their origin [4]. These lineages were
defined as Indo-Oceanic (lineage I), East Asian (lineage II, including Beijing), East African In-
dian (lineage III), Euro-American (lineage IV), West-Africa (lineage V, M. africanum I) and
West Africa (lineage VI; M. africanum II). Lineages I, V and VI were considered “ancient” and
II to IV “modern” in relation to the presence or absence of the TbD1 genomic region, deleted
in modern strains [4].
Independently in an earlier study, a distinction between three genetic groups ofM. tubercu-
losis was achieved based on two non-synonymous polymorphisms occurring at high
frequency in the genes encoding catalase-peroxidase and the A subunit of gyrase, which led to
a classification in three principal genetic groups (PGG); group 1 bacteria being ancestral to
groups 2 and 3 [5]. Additional genotyping methods such as the presence or absence of spacer
oligonucleotides (spoligotyping), variable number of repeats (MIRU-VNTRs), or single nucle-
otide polymorphisms (SNPs), have not only provided further resolution at the sublineage level
but also corroborated split ofM. tuberculosis into similar main lineages; interested readers may
refer to a recent review for comparison of spoligotyping-based nomenclature ofM. tuberculosis
lineages vs. PGG groupings, SNPs and SNP based cluster groups (SCGs), and LSP-based line-
ages [6].
M. tuberculosismolecular profiling allows today not only to study the global biodiversity
and the phylogeographical variations of tubercle bacilli [6], but also to determine if recurrent
disease is caused by endogenous reactivation or exogenous reinfection, to look for associations
of particularM. tuberculosis strains with their clinical behavior, to determine whether out-
breaks in specific geographical areas are caused by the same (cluster) or by multiple strains, if
some strains are more transmissible than others, and whether some strains are more prone to
develop drug resistance [7][8][9]. It undeniably constitutes an important tool for tuberculosis
control and epidemiological studies today.
Chile has reached very low TB rates after decades of sustained decline related to economic
development and a robust and well-coordinated National Tuberculosis Program. However, in
the last 5 years TB incidence rate has become stationary around 13/100,000; with over 2000
new cases diagnosed per year. Newer policies will have to be addressed and implemented in the
country to reverse this situation, such as strategies to detect earlier infections in high-risk
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groups, introducing contact tracing and targeted tuberculosis preventive therapy. In this con-
text, the introduction of molecular epidemiology tools is a valuable asset to help understand
local TB transmission dynamics. Two previous reports published locally have described geno-
typing of a small number of MTBC strains collected at the Xth region in year 2006 and Metro-
politan Region in 2013, and the most frequently identified spoligotypes were T1 (24%) and
LAM (39.5%), respectively [10, 11]. However, none of those reports included phylogenetic
analysis or epidemiological data to distinguish local versus imported strains.
We hereby report on a preliminary study to describe genetic diversity and main genotypic
lineages ofM. tuberculosis complex clinical isolates circulating in Santiago, Chile, and compare
our findings with MTB genetic epidemiology studies from other South American countries.
Materials and Methods
Patients and bacterial isolates
This study describes genotyping results of a total of 103M. tuberculosis isolates collected from
August 2008 to September 2013, the majority of strains (84.5%) between 2011 and 2013. The
specimens were obtained from the same number of pulmonary TB patients, in 22 outpatient
clinics and 3 large hospitals in the central area of Santiago city, with a reference TB incidence
of 16.6 per 100,000 population for the year 2012. Our samples represent around 6.44% of all
smear-positive TB cases for that period in the whole Metropolitan Region. Basic demographic
data (age, gender and country of origin) was obtained from mandatory reports included in the
National Tuberculosis Program registry and anonymized. Strains included newly and previ-
ously treated cases, and none of the samples were duplicated from a single patient. Culture pro-
cessing and strain isolating were performed at the central clinical laboratories from the
Hospital San Borja Arriarán and Red de Salud de la Pontificia Universidad Católica de Chile.
Positive cultures grown over the Lowenstein—Jensen medium or in automatized liquid
(MGIT) culture were isolated and DNA extracted by standard methods. Testing for susceptibil-
ity to first line drugs was determined over Lowenstein—Jensen medium using the proportion
method [12] at the national reference laboratory (ISP). According to programmatic guidelines
susceptibility testing was done in patients considered to be at risk for drug resistance, namely
patients with TB treatment failure, default or relapse, exposed to a drug-resistant TB case,
HIV-associated TB and cases in migrants from countries with high prevalence of drug
resistant TB.
Nucleic acid extraction and genotyping
M. tuberculosis complex species were confirmed for all strains by a specific PCR for gyrase
B (gyrB) with primers described by Kasai et al. [13]. Briefly each amplification reaction con-
tained: 12,5μl 2X Promega premix, 2μl of each primer 10μM (forward and reverse), 0,2 μl of
GoTaq flexi 5U/μl (Promega) DNA polymerase, 5 μl of nuclease-free distilled water and 5 μl of
DNA from samples or control, in a final volume of 25μl. Thermal cycling conditions were as
follows: 95°C, 2 minutes followed by 10 cycles of 95°C, 30 seconds; annealing temperature
step-downs every cycle of 1°C (from 65°C to 55°C); 72°C, 30 seconds. The annealing tempera-
ture for the final 35 cycles was 55°C with denaturation and extension phases as above. PCR
products were analyzed through electrophoresis in 1.5% agarose gels that were stained with
ethidium bromide.
Mycobacterial DNA was prepared by heat inactivation and lysis by sonication, and stored
at-20°C until use. Spoligotyping analysis was performed by using a commercial source for
membranes and reagents (Ocimum Biosolutions BV) as described by Kamerbeek et al. [14]
[15]. A total of 43 spacers between the direct repeats in the target region were amplified by
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using DRa biotinylated at 5’ end and DRb primers. The PCR products were hybridized to a
membrane containing 43 oligonucleotides by reverse line blotting. A positive control with
M. tuberculosisH37Rv strain andM. bovis BCG were used in each run.
Standard 12-loci MIRU-VNTRs typing was manually performed by conventional PCR am-
plification of 12 of 41 loci: 02, 04, 10, 16, 20, 23, 24, 26, 27, 31, 39 and 40, as previously de-
scribed [16]. Each locus was amplified separately by simplex PCR with GoTaq flexi DNA
polymerase (Promega). Products were analyzed by electrophoresis using 1.5–2% agarose (Pro-
mega, Fitchburg, USA) gels. From the gel images, the corresponding MIRU-VNTR bands were
interpreted as copy numbers based on a reference table [17].
Computer assisted genotype analysis and comparison with databases
Spoligotype patterns as octal codes were entered in the SITVIT2 proprietary database of the
Institut Pasteur de la Guadeloupe which is an updated version of the previously released SIT-
VITWEB database (available online at http://www.pasteur-guadeloupe.fr:8081/SITVIT_
ONLINE/) [18]. At the time of the analysis on August 2014, the database contained genotypes
of about 112,000M. tuberculosis clinical isolates from about 170 countries of origin. In this da-
tabase, Spoligotype International Type (SIT) and MIRU International Type (MIT) designates
patterns shared by two or more patient isolates, whereas “orphan” designates patterns reported
for a single isolate [18] [19]. Genotypic lineages were assigned according to the rules described
in SITVITWEB [18] in which the LSP-based Euro-American lineage (lineage IV) is split in
Latin American and Mediterranean (LAM), ill-defined T, Haarlem (H), X, and S lineages. Im-
portantly, the nomenclature “East-African Indian” (EAI or lineage III) denotes two altogether
differentM. tuberculosis clades by spoligotyping vs. LSPs [6]; EAI by spoligotyping was named
“Indo-Oceanic” by LSPs, while EAI by LSPs corresponds to Central-Asian (CAS) in the SIT-
VIT2 database [6]. Note that lineages could be subdivided into sublineages.
Data were also analyzed using MIRU-VNTRplus web server (http://www.miru-vntrplus.
org/) which is a collection of 186 strains representing the majorM. tuberculosis complex line-
ages [19][20]. This database contains information of strain species, lineage, country together
with copy numbers of 24 MIRU loci, spoligotyping patterns, regions of difference (RD) pro-
files, single nucleotide polymorphisms (SNPs), drug susceptibility data, and IS6110-RFLP
fingerprint images.
Phylogenetic analysis
BioNumerics software version 6.6 (Applied Maths, Sint-Martens-Latem, Belgium) was used to
compare spoligotypes and MIRU-VNTRs patterns, by drawing Minimum spanning trees
(MSTs) in order to visualize evolutionary relationships between the clinical isolates in our
study. MSTs are undirected graphs in which all samples are connected together with the fewest
possible connections between nearest neighbors. An Unweighted Pair Group Method with
Arithmetic mean (UPGMA) tree was also constructed using MLVA Compare software (http://
www.ridom.de/mlvacompare/) to visualize deeper associations between spoligotypes and
MIRU-VNTRs involved in this study.
Ethics Statement
Prior to the start of the study, ethical approval was obtained from Ethical Committee of Ponti-
ficia Universidad Católica de Chile School of Medicine (CEC-MedUC). The microbiological
records and basic demographic information of patients were anonymized and de-identified
prior to analysis. Therefore, informed consent was not required and was specifically waived by
the Ethical Committee.
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Results
In total, 103M. tuberculosis isolates were collected and analyzed; patients providing samples
were 61.2% males and 38.8% females, with a mean age of 45.3 (range 3–93) and 51.05 years old
(range 22–93), respectively. Although all patients were current residents in Santiago, Chile,
11.6% were foreign-born migrants with main country of origin being Peru (66.6%) and Bolivia
(25%).
Spoligotyping of the 103 isolates revealed a total of 56 different patterns: 16 patterns
(15.5%) corresponded to orphan strains in the SITVIT2 database, not yet reported, and 40 pat-
terns (containing 87 strains) corresponded to shared-types or SITs in the SITVIT2 database.
Among these 40 shared-types, 2 isolates from the present study in Chile matched an orphan
strain recorded in the database from USA, therefore a new shared-type, SIT4013, was created.
In addition, a total of ten 12-loci MIRU patterns (fromMIT 1670 to MIT 1679) were newly
created. Description of the 40 SITs (n = 87 isolates) and corresponding spoligotyping defined
lineages/sublineages is shown in Table 1. Among orphan isolates, we noted similar spoligotyp-
ing patterns (with absence of spacer 6) among orphans Or08, Or11, and Or12 within our
study. (S1 Table)
Distribution of main lineages for the 103 isolates according to SITVIT analysis, showed that
35 (34%) belonged to the LAM family; 34 (33%) belonged to the ill-defined T super-family; 17
(16.5%) belonged to the Haarlem (H) lineage; 3 (2.9%) belonged to the X lineage; 2 belonged to
the S lineage and 2 (1.9%) belonged to the Beijing lineage. The rest belonged to “Unknown” or
single strain lineages, and included genotypes such as Bovis, CAS, and AFRI (Table 2). Among
all LAM strains (n = 35), the main sublineages were LAM3 (42.9%), LAM9 (40%) and LAM6
(8.6%). Among the ill-defined T super-family (n = 34) its prototype T1 (58.8%) was the 1st
most frequent pattern in our study, followed by T3 (20.6%). The H lineage represented 16.5%
(n = 17) of isolates subdivided in H3 (88.2%), and H1 (11.8%) sublineages. Diversity of strains
among migrants (n = 12) were much higher and included lineages such as Beijing and CAS,
which were uncommon among non-migrants. Comparison of lineage allocation by SITVIT
and MIRU-VNTRplus was highly concordant for the majority of strains with the exception of
T lineages: 27 out of 34 T strains on SITVIT analysis were reclassified by MIRU-VNTR, mostly
as H (40.7%) and LAM (22.2%) (data shown in S2 Table).
Spoligotype analysis identified clustering (of 3 or more isolates) among 48 of 103 isolates,
whereas with MIRU12 identified clustering (of 3 or more isolates) among only 14 of 103
strains. As shown in Table 3, the most frequently clustered spoligotypes were SIT33/LAM3
(n = 11, 10.7%), SIT53/T1 (n = 9, 8.8%), SIT50/H3 (n = 8, 7.8%) and SIT37/T3 (n = 7, 6.8%).
The high presence of SIT37/T3 (6.8% of strains) was noteworthy as this SIT is usually more
commonly found in Eastern Africa, and migration from Africa is highly rare in Chile. With re-
spect to 12-loci MIRU clustering, the most frequently clustered isolate was 12-MIT585 (n = 6),
that in SITVIT2 database corresponds to spoligotypes SIT37/T3 (n = 5) and SIT281/T1
(n = 1). Furthermore, in the SITVIT2 database, 12-MIT585 was present in 6 isolates only: in
Spain from two South American patients (from Ecuador and Peru, respectively); and in USA
(n = 1), Caribbean (n = 2), and Belgium (n = 1).
Minimum spanning trees (MSTs) illustrating evolutionary relationships between spoligo-
types and 12-MIRU-VNTRs were constructed for all strains included in the present study
(n = 103). Fig. 1A shows a MST based on spoligotypes in which three major groups belonging
to the modern group PGG2/3 (LAM, T, H, X, S) were evident as highly predominant (repre-
senting 88.3% of all strains), most notably LAM (n = 35, 34%), T (n = 34, 33%) and Haarlem
(n = 17, 16.5%). More distance was evident among isolates belonging to the T sublineages than
among those integrating the LAM sublineages (Fig. 1A). In contrast, when MST was
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Table 1. Description of 40 shared-types (SITs; n = 87 isolates) and corresponding spoligotyping defined lineages/sublineages starting from a
total of 103 M. tuberculosis strains isolated in Santiago, Chile.
SIT* Spoligotype Description Octal Number Nb. In
study (%)
% in study vs.
database
Lineage** Unique vs.
Clustered
SIT***
1 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 000000000003771 2 (1.94) 0.02 Beijing Clustered
20 ■■□■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 677777607760771 1 (0.97) 0.11 LAM1 Unique
33 ■■■■■■■■□□□■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 776177607760771 11 (10.68) 0.84 LAM3 Clustered
34 ■■■■■■■■□□■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 776377777760771 2 (1.94) 0.23 S Clustered
37 ■■■■■■■■■■■■□■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 777737777760771 7 (6.8) 1.34 T3 Clustered
39 ■■■■■■■■■■■■■■■■■■□■■■□□■■■■■■■■□□□□■□□■■■■ 777777347760471 2 (1.94) 1.35 T4-CEU1 Clustered
42 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 777777607760771 7 (6.8) 0.2 LAM9 Clustered
49 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■□■■■ 777777777720731 1 (0.97) 0.39 H3 Unique
50 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■ 777777777720771 8 (7.77) 0.2 H3 Clustered
52 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□■■■ 777777777760731 3 (2.91) 0.31 T2 Clustered
53 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 777777777760771 9 (8.74) 0.14 T1 Clustered
58 ■■■■■■■■■■■■■■■■■■■□■■□■■■■■■■■■□□□□■■■■■■■ 777777557760771 1 (0.97) 0.52 T5-
Madrid2
Unique
64 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■□■■■□□□□■■■■■■■ 777777607560771 1 (0.97) 0.25 LAM6 Unique
91 ■■■□□□□□□□□□□■■■■□■■■■■■■■■■■■■■□□□□■■■■■■■ 700036777760771 1 (0.97) 0.28 X3 Unique
161 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■□□□□□■■■■■■■ 777777607740771 1 (0.97) 7.69 LAM9 Unique
180 ■■□■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■ 677777777720771 1 (0.97) 1.67 H3 Unique
203 ■■■□□□□■■■■■■■■■■■■■■■□□□□□□□□□□□□□■■■■■■■■ 703777740001771 1 (0.97) 4.76 CAS Unique
211 ■■■■■■■■□□□■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 776137607760771 3 (2.91) 2.83 LAM3 Clustered
219 ■■■■■■■■■■■■■□□□□□■■■■■■■■■■■■■■□□□□■■■■■■■ 777740777760771 1 (0.97) 1.16 T1 Unique
222 ■■■■■■■■■■■■■■■■□□□□□■■■■■■■□■■■□□□□■■■■■■■ 777774077560771 2 (1.94) 2.06 Unknown Clustered
281 ■■■■■■■■■■■■■■■■□■■■■■■■■■■■■■■■□□□□■■■■■■■ 777775777760771 1 (0.97) 3.23 T1 Unique
336 ■■■■■■■■■■■■■■■■■□■■■■■■■■■■■■■■□□□□■■■□■■■ 777776777760731 1 (0.97) 0.85 X1 Unique
373 ■■■■■■■■■■■■■■■■■■■■■■■□■■■■■■■■□□□□■■■■■■■ 777777767760771 1 (0.97) 1.47 T1 Unique
390 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■■■■■■■ 777777777620771 1 (0.97) 3.03 H3 Unique
452 ■■■■■■■■■■■■■■■■■■■■□□□□■■□□■■■■□□□□■■■■■■■ 777777606360771 1 (0.97) 5.88 LAM9 Unique
738 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■□□ 777777607760760 1 (0.97) 16.67 LAM9 Unique
746 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□■□□□□■■■■■■■ 777777777520771 1 (0.97) 2.86 H3 Unique
948 ■■■■■■■■■■■■■■■■■■■■■■■□□□□□□□□■□□□□■■□□□■■ 777777760020611 1 (0.97) 8.33 H3 Unique
1277 ■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■■□□□□■■■■■■■ 777777207760771 2 (1.94) 6.67 LAM9 Clustered
1293 ■■□■■■■■□□□■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 676177607760771 1 (0.97) 12.5 LAM3 Unique
1355 ■■■■■■■■■■■■■■■■■■■□□□□□■■■■□■■■□□□□■■■□■■■ 777777407560731 1 (0.97) 0.54 LAM Unique
1474 ■■□■■■■■■■■■■■■■■■■■□□■□■■■■■■■■□□□□■■■■■■■ 677777627760771 1 (0.97) 33.33 T1 Unique
1624 ■■■■■■■■□□□■■■■■■■■■□□□□■■■■□■■■□□□□■■■■■■■ 776177607560771 1 (0.97) 16.67 LAM Unique
1877 ■■■□■■■■■□■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 737377777760771 1 (0.97) 7.14 T1 Unique
1914 □■■■■■■■■■■■■■■■■■■■□□□□■■■■□■■■□□□□■■■■■■■ 377777607560771 1 (0.97) 16.67 LAM6 Unique
2030 ■■■■■■■■■■■■■■■■■■■■■□□□■□□□□□□■□□□□■■■■□■■ 777777704020751 1 (0.97) 33.33 H1 Unique
2273 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■□■□□□□■■■□■■■ 777777607720731 1 (0.97) 25 H3 Unique
2623 ■■■□□□□□□□□□□□□□□□□□□□□□■□□□□□□■□□□□■■■■■■■ 700000004020771 1 (0.97) 33.33 H1 Unique
2745 ■□■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■□■■ 577777607760751 1 (0.97) 33.33 LAM9 Unique
(Continued)
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constructed using 12-loci MIRU-VNTRs (Fig. 1B), isolates belonging to LAM appeared more
distant than other sublineages, and for T genotype, two distinct and clearly separated groups
were observed (Fig. 1B). The MST combining spoligotyping and MIRU-VNTRs results
(Fig. 1C) highlights main SIT/12-MIT couples—in particular a SIT37/12-MIT585 cluster
(n = 5 strains) and a SIT42/12-MIT190 cluster (n = 3 strains), as well as other smaller clusters
containing 2 isolates. Briefly, there was an overall agreement in the manner in which the two
genotyping methods grouped isolates in major lineages/sublineages. The UPGMA tree based
on the combination of spoligotypes and 12-loci MIRUs using MLVA Compare (S1 Fig.) further
corroborated the observations made.
Susceptibility data was available for 25/103 (24.3%) of all strains and revealed 1 case of
multi-drug resistant (MDR) tuberculosis, 2 cases of rifampicin resistance and 2 cases of isonia-
zid monoresistance. No correlation with strain origins was possible due to the small number of
resistant strains.
Table 1. (Continued)
SIT* Spoligotype Description Octal Number Nb. In
study (%)
% in study vs.
database
Lineage** Unique vs.
Clustered
SIT***
4013* ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□□■□□■■■■ 777777777600471 2 (1.94) 66.67 Unknown Clustered
* A total of 39/40 SITs containing 85 isolates matched a preexisting shared-type in the database, whereas 1/40 SIT (n = 2 isolates) was newly created. A
total of 13/40 SITs containing 60 isolates were clustered within this study (2 to 11 isolates per cluster) while 27/40 SITs containing 27 strains were unique
(for total unique strains, one should add to this number the 16 orphan strains, which brings the number of unclustered isolates in this study to 43/103 or
41.75%, and clustered isolates to 60/103 or 58.25%). Note that SIT followed by an asterisk indicates “newly created” SIT due to 2 or more strains
belonging to an identical new pattern within this study or after a match with an orphan in the database; SIT designation followed by number of strains:
4013* this study n = 2, USA n = 1.
** Lineage designations according to SITVIT2 using revised SpolDB4 rules; “Unknown” designates patterns with signatures that do not belong to any of
the major lineages described in the database.
*** Clustered strains correspond to a similar spoligotype pattern shared by 2 or more strains “within this study”; as opposed to unique strains harboring a
spoligotype pattern that does not match with another strain from this study. Unique strains matching a preexisting pattern in the SITVIT2 database are
classified as SITs, whereas in case of no match, they are designated as “orphan”.
doi:10.1371/journal.pone.0118007.t001
Table 2. Distribution of main lineages according to SITVIT2 starting from a total of 103 M.
tuberculosis strains isolated in Santiago, Chile.
Lineage Number of strains (%)
AFRI 1 (0.97)
Beijing 2 (1.94)
BOV 1 (0.97)
CAS 1 (0.97)
H 17 (16.50)
LAM 35 (33.98)
S 2 (1.94)
T 34 (33.01)
X 3 (2.91)
Unknown 7 (6.80)
doi:10.1371/journal.pone.0118007.t002
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Table 3. Description of clusters containing 3 or more isolates in this study, and their worldwide distribution in the SITVIT2 database.
SIT (Lineage) Octal Number Spoligotype Description Number
(%) in
study
% in study
vs.
database
Distribution in Regions with
3% of a given SIT*
Distribution in countries
with 3% of a given
SIT**
33 (LAM3) 776177607760771 11 (10.68) 0,84 AMER-S 34.96, AFRI-S 24.81,
AMER-N 12.14, EURO-S 10.84,
EURO-W 6.26, AMER-C 4.12
ZAF 24.81, PER 16.95,
USA 12.14, BRA 10.92,
ESP 6.79, ARG 4.35, FXX
4.05, ITA 3.51, HND 3.28
■■■■■■■■□□□■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■
53 (T1) 777777777760771 9 (8.74) 0,14 EURO-W 15.0, AMER-S 14.35,
AMER-N 12.93, EURO-S 9.02,
EURO-N 7.17, ASIA-W 7.0, AFRI-
S 4.76, AFRI-E 4.46, ASIA-E 4.09,
AFRI-N 3.37, EURO-E 3.13, CARI
3.1, AMER-C 3.1
USA 12.65, FXX 7.55, BRA
5.62, ITA 5.11, ZAF 4.65,
PER 3.74, TUR 3.33, AUT
3.28
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■
50 (H3) 777777777720771 8 (7.77) 0,2 AMER-S 26.08, EURO-W 14.98,
AMER-N 14.98, EURO-S 9.84,
CARI 4.96, EURO-E 4.71, EURO-
N 4.66, AFRI-N 3.63, AFRI-S
3.45, AFRI-M 3.22
USA 14.96, PER 13.65,
BRA 7.15, FXX 5.87, AUT
5.19, ITA 4.63, ESP 4.63,
ZAF 3.45, CMR 3.17, CZE
3.12
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■
37 (T3) 777737777760771 7 (6.8) 1,34 AFRI-E 19.19, EURO-N 11.9,
EURO-W 11.52, ASIA-W 10.56,
AMER-S 9.21, AMER-N 8.64,
ASIA-E 6.14, EURO-S 5.76,
EURO-E 4.42, ASIA-S 3.65,
AFRI-S 3.26
ETH 16.7, USA 7.68, SWE
5.18, SAU 4.99, CHN 4.99,
FXX 4.22, ITA 4.03, BRA
3.65, ZAF 3.26, DNK 3.26
■■■■■■■■■■■■□■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■
42 (LAM9) 777777607760771 7 (6.8) 0,2 AMER-S 31.16, AMER-N 11.33,
EURO-S 10.81, EURO-W 9.04,
AFRI-N 8.19, EURO-N 4.68, CARI
4.05, AMER-C 3.4, AFRI-E 3.4,
AFRI-S 3.02
BRA 13.07, USA 11.33,
COL 7.28, MAR 6.73, ITA
6.25, FXX 4.82, PER 3.54,
ESP 3.2, VEN 3.17, ZAF
3.02
■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■
52 (T2) 777777777760731 3 (2.91) 0,31 EURO-W 18.95, ASIA-E 14.97,
EURO-N 13.4, AMER-N 11.62,
EURO-S 5.13, ASIA-W 5.13,
AFRI-M 5.13, AFRI-E 4.82,
EURO-E 4.19, AMER-C 3.35,
AMER-S 3.04
CHN 11.62, USA 11.2,
SWE 9.42, FXX 8.69, BEL
4.71, CMR 4.19, ITA 3.35,
JPN 3.14, ETH 3.14
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□■■■
211 (LAM3) 776137607760771 3 (2.91) 2,83 AMER-N 30.19, AMER-C 20.76,
EURO-W 19.81, AMER-S 18.87,
EURO-S 7.55
USA 30.19, MEX 20.76,
FXX 18.87, BRA 11.32,
ESP 4.72
■■■■■■■■□□□■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■
* Worldwide distribution is reported for regions with more than 3% of a given SITs as compared to their total number in the SITVIT2 database. The
definition of macro-geographical regions and sub-regions (http://unstats.un.org/unsd/methods/m49/m49regin.htm) is according to the United Nations;
Regions: AFRI (Africa), AMER (Americas), ASIA (Asia), EURO (Europe), and OCE (Oceania), subdivided in: E (Eastern), M (Middle), C (Central), N
(Northern), S (Southern), SE (South-Eastern), and W (Western). Furthermore, CARIB (Caribbean) belongs to Americas, while Oceania is subdivided in 4
sub-regions, AUST (Australasia), MEL (Melanesia), MIC (Micronesia), and POLY (Polynesia). Note that in our classification scheme, Russia has been
attributed a new sub-region by itself (Northern Asia) instead of including it among rest of the Eastern Europe. It reflects its geographical localization as well
as due to the similarity of specific TB genotypes circulating in Russia (a majority of Beijing genotypes) with those prevalent in Central, Eastern and South-
Eastern Asia.
** The 3 letter country codes are according to http://en.wikipedia.org/wiki/ISO_3166-1_alpha-3; countrywide distribution is only shown for SITs with 3%
of a given SITs as compared to their total number in the SITVIT2 database. Note that FXX code designates Metropolitan France.
doi:10.1371/journal.pone.0118007.t003
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Discussion
In the present study, we provided the first insight into the population structure ofM. tuberculo-
sis isolates in Santiago, Chile, showing the predominance of both the LAM and T lineages. This
lineage distribution does not differ significantly as compared to descriptions reported from
other Latin American countries where predominant isolates usually belong to three major
clades: LAM, T, and Haarlem; in different proportions depending on specific country and year
of isolation, but with generally a clear predominance of LAM (Table 4). Thus, in Brazil, the pre-
dominantM. tuberculosis lineage isolated between 1996 and 2005 was LAM (46%); followed by
T (18.6%) and Haarlem (12.2%) families [21]. Similarly, in Argentina between years 2006 and
Fig 1. A minimum spanning tree (MST) illustrating evolutionary relationships between spoligotypes and 12-loci MIRU-VNTRs in Santiago, Chile
(n = 103 isolates). (A)MST constructed on all spoligotypes; (B)MST constructed on all 12-loci MIRUs alone; and (C)MST constructed on the combination of
spoligotypes and 12-loci MIRUs. The phylogenetic tree connects each genotype based on degree of changes required to go from one allele to another. The
structure of the tree is represented by branches (continuous vs. dashed and dotted lines) and circles representing each individual pattern. Note that the
length of the branches represents the distance between patterns while the complexity of the lines (continuous, gray dashed and gray dotted) denotes the
number of allele/spacer changes between two patterns: solid lines, 1 or 2 or 3 changes (thicker ones indicate a single change, while the thinner ones indicate
2 or 3 changes); gray dashed lines represent 4 changes; and gray dotted lines represent 5 or more changes. The size of the circle is proportional to the total
number of isolates in our study, illustrating unique isolates (smaller nodes) versus clustered isolates (bigger nodes). The separation inside circle also
indicates the number of strains. The color of the circles indicates the phylogenetic lineage to which the specific pattern belongs. The labels of nodes indicate
SITs and 12-MITs respectively in Fig. A and B; and main SIT/12-MIT couples (n 2 isolates) are represented in Fig. C.
doi:10.1371/journal.pone.0118007.g001
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2007, the most common lineages were also LAM (50%), followed by T1 (18%) and Haarlem 1
(10%) and in Colombia, for strains isolated between years 1995 and 2007, LAM was present in
49.3% of isolates; Haarlem, in 25% and T group, in 13.8% [22] [23]. On the contrary, in Peru,
which is Chile’s northern neighbor country, this proportion is lost as LAM strains have been
found in lower percentage ranging from only 12.6 to 33.3% [24] [25] [26] [27].
A particular characteristic that has been ascribed to the LAM family is that they are unique
to harbor a significant proportion of strains with a specific deletion named RDRio characterized
by a single long sequence polymorphism (>26.3 kb) with deletion or modification of 10 genes
[28]. LAM1 (SIT20) and LAM2 (SIT17) are exclusively of the RDRio genotype, LAM4, LAM5,
Table 4. Main published studies (2006–2013) reporting distribution of Mycobacterium tuberculosis lineages in Central and South America.
Country, Period (years) and
Reference
Numbe of
strains
Harleem
(H)
T LAM S U Beijing X EAI Orphans or
Unclassified
Argentina, 2006–2007 [22] 157 37% 18% 23% NR NR NR NR NR NA
H1 10% T1 18% LAM9 13%
H2 16% LAM3 10%
H3 11%
Argentina, 2003–2009 [51] 787 (MDR
only)
36.3% 13.9% 38.8% 2.8% 1.7% 1.5% 0.9% NR 3.8%
T1
8.9%
LAM3
16.4%
Argentina, Brasil, Chile,
Colombia, Venezuela, 2004–2008
[52]
951 (MDR
only)
28.9% 17.4% 37.2% NR NR 1.3% NR NR NR
French Guyane, 1994–2003 [34] 744 21.7% 30.1% 19.7% 1.5% NR 1.0% 6.5% 4.8% 6.5%
Brasil, 1996–2005 [21] 1991 12.2% 18.6% 46% 1.9% NR NR 4.7% 0.85% 15%
LAM9
10.3%
Colombia 1995–2007[23] 152 25% 13.8% 49.3% 3.3% NR 0.6% 1.3% NR 6.6%
Colombia 2005–2008 [33] 414 44.3% 38.5% 0
H1 23.4% LAM9:29.9%
Paraguay, 2003 [39] 220 18.2% 8.6% 52.3% 9.5% NR 0.5% 0.9% NR NR
Peru, 1996–2004 [24] 391 (MDR
only)
11.4% 27.5% 33.3% NR 0.3% 4.9% 4.4% NR 18%
H1 5.7% T1
22.1%
LAM5
12.2%
X3
4.4%
H3 5.7% T2
4.9%
LAM9 9.9%
T5
0.5%
LAM1 6.5%
Peru, 2004–2006 [25] 323 23.8% 22.3% 23.8% NR NR 9.3% NR NR 13.3%
Peru, 2009 [26] 199 34.9% 15.6% 12.6% 1.0% 8.5% 14.1% 3.5% NR 15.1%
Peru, 1999–2005[27] 794 H3 16.4% T1
12.3%
18.7% NR NR 5.5% 2.8% NR 3.4%
H1 3.9% LAM3 8.3%
LAM9 7.4%
Venezuela, 1998–1999 [38] 670 3% 13% 74% 1.0% NR 0% NR NR 9%
Venezuela, 1997–2006 [40] 1298 5% 10.6% 53% 1.9% 9.7% 0.4% 1.2% 0.2% 17.9%
Bolivia, 2010 [30] 99 39.4% 22.2% 26.3% 2% NR NR 1% NR 9.1%
H3 30.3% T1
21.2%
LAM3
15.2%
doi:10.1371/journal.pone.0118007.t004
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LAM6 and LAM9 are composed of both RDRio and wild type genotypes, and LAM3 composed
exclusively of wild type isolates. This RDRio genotype was found in 26.5% (72/270) of all tuber-
culosis cases in a recent large retrospective study from Brazil, extrapolating that this genotype
could be widely spread in that country. RDRio M. tuberculosis genotypes were suspected of
being more virulent and able to cause disease more efficiently, however, not all researchers
have supported this view, and a large survey found disease caused by this strain was not clini-
cally distinctive or more severe than disease caused by non-RDRio [29].
In contrast with other Latin-American countries where LAM is the most prevalent lineage,
a shift towards increased proportion of Haarlem lineage was observed in a recent survey of 199
isolates carried out in the North-eastern part of Lima, Peru, where H strains were found in a
predominant proportion of 29.6%, followed by T at 15.6%, Beijing at 14.1% and LAM at only
12.6% [26]. Similarly, Bolivia also recently reported a predominance of H genotype in up to
40% of isolates studied in 2010. [30] This Haarlem genotype has the particular significance of
having been involved in several outbreaks of MDR-tuberculosis [31] [32]. Furthermore, a re-
cent study conducted in Colombia with strains isolated between 2005 and 2008 has also shown
an increase in Haarlem strains actually reaching 44.3% in the city of Medellín, and included a
large proportion of MDR among strains belonging to SIT45/H1 [33].
Descriptions for main circulating strains in South-American countries have long described
the Euro-American lineage to be widely predominant, and this has been used to support a Euro-
pean dissemination from either early settlement or trade associations [34]. It is of interest to note
that this model, however, has been unable to explain the profuse archaeological evidence for the
presence of tuberculosis in the Americas before European contact and recent comparative geno-
mics from 1,000-year-old mycobacterial found in Peruvian human skeletons described members
of the MTBCmost closely related to those adapted to seals and sea lions than those from humans
[35]. Worldwide, lineage-specific differences in the virulence and transmissibility of clinical iso-
lates have been reported across independent experimental systems with modern lineages, such as
Beijing and Euro-American Haarlem strains believed to exhibit more virulent phenotypes com-
pared with ancient lineages, such as East-African-Indian andM. africanum [36]. Strains belong-
ing to the Beijing genotype have been associated with increased transmission risk, large
outbreaks and drug resistant TB in many parts of the world. This genotype was only recently de-
scribed for the first time in Chile and is infrequently observed in TB patients in South America
with the exception of Peru [37]. On one hand, in Argentina, Brazil, Colombia, Chile, Ecuador,
Paraguay and Venezuela, the prevalence of Beijing lineage strains reported has been generally
lesser than 2% [21] [23] [28] [37] [38] [39] [40] [41]. On the other hand, the prevalence of Bei-
jing genotype in Peru is exceptionally high and has been estimated between 4.9% and 14.1%, al-
though not clearly associated with MDR tuberculosis [24] [25] [26] [27]. Ritacco et al. speculated
that the Beijing lineage strains were first introduced into Peru, and eventually into other South
American countries, when Peru received a significant number of Chinese immigrants in the
mid-19th century. The need for vigilance is further warranted by another recently published
study that included a total of 200 Beijing strains from Peru where 24 loci VNTR analysis showed
a high clustering rate (80.3%) and a high recent transmission index (RTIn−1 = 0.707), strongly
suggesting active and on-going transmission of Beijing lineage strains in the surveyed area [42].
In the present study, susceptibility data was only available for a minority of isolated strains,
as susceptibility determination was not required routinely for newly acquired tuberculosis due
to the general low MDR rate for the country. With regard to the possibility of strains-other
than Beijing- potentially associated with drug resistance, it is of interest to note that in a recent
large survey of phylogenetic clades collected over a seventeen-year period in the French De-
partment of the Americas, X and LAM lineages were overrepresented in drug-resistant and
MDR-TB cases, respectively, and also, four predominant spoligotypes were significantly
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associated with drug resistance corresponding to SIT20/LAM1, SIT64/LAM6, SIT45/H1 and
SIT46/undefined lineage [43].
The effects of migration on the epidemiology of tuberculosis has been evaluated by many
studies by determining genotypic lineages on the isolates and also providing general informa-
tion on the phylogeographical origin of the strains circulating in the study area [44] [45]. In the
present study, 11.6% of strains belonged to migrant population, which is a slightly higher pro-
portion in relation to the national reports (7%), but consistent with our patients who were re-
cruited in the central area of Santiago where the highest immigration rate is found [46].
Among this group, the most prevalentM. tuberculosis lineage found was also LAM, although
infrequently isolated strains such as CAS—belonging to a migrant from Nepal—and a Beijing
strain belonging to a migrant from Peru were also detected. As there is considerable evidence
that genetic susceptibility can influence on tuberculosis acquisition risk, such as the higher sus-
ceptibility conferred by individual polymorphisms in genes for natural resistance-associated
macrophage protein (NRAMP1), vitamin D receptor, or mannose-binding protein [47] [48], it
has been suggested that different ethnic groups may have different susceptibility for particular
M. tuberculosis strains [49]. This will be an important issue to further explore in Chile and
among other populations from Latin America where different ethnic backgrounds coexist and
where furthermore, most of ethnic groups are concentrated in areas of poverty and crowding,
adding strong confounding factors that can determine a higher prevalence of tuberculosis dis-
ease among the most vulnerable.
Finally, it is important to mention that both genotyping methods used in present study are
based on analysis of a limited number of loci, and it has been described that VNTR loci as well
as particular spoligotyping patterns can exhibit variable discriminatory power in different my-
cobacterial lineages. Rapid markers evolution with a tendency to converge can lead to signifi-
cant amounts of homoplasy, and hence the limitations of these tools in defining deep
phylogenetic groups inM. tuberculosis complex or other bacteria [50]. This can explain discor-
dant findings for T and H lineages classification between both SITVIT2 and MIRU-VNTRplus
databases (S2 Table). Future investigations by use of more discriminatory tools such as whole
genome sequencing (WGS) might be helpful to identify true phylogenetic relationships and
also obtain a more precise evaluation of TB transmission.
Among orphan isolates, we noted similar spoligotyping patterns (with absence of spacer 6)
among orphans Or08, Or11, and Or12 within our study (S1 Table). The ancestral genotypes
found among orphan patterns in our study are most probably suggestive of ancestral lineages
undergoing extinction after an initial distant contact with patient(s) infected with Africanum
lineage or the African continent. This finding may suggest a probable ancient link with Africa-
num lineage and the African continent. Interestingly thanks to the “SpolSimilaritySearch tool”
under development in SITVIT2 database, we detected that a similar spoligotype was found
once in Italy: ■■■■■□■□□□□□■■■■■■■■□□□□■■■■■■■■■■■■□□□■■■■; octal code
764077607777071; AFRI_2. However, one cannot exclude the possibility of a recent introduc-
tion of such strains in Chile.
A supplemental figure (S2 Fig.) has been added to support the finding of high presence of
SIT37/T3 in Chile. This figure shows geographical maps based on SITVIT2 interrogation prior
to entry of present dataset to summarize percentages of SIT37 (A) and strains belonging to T3
sub-lineage (B), by country. Note that this distribution should not be confounded with data in
Table 3, which shows proportions of a given spoligotype in the global database. For example,
we have 7 strains for SIT37/T3 representing 6.8% of our study sample. However when checked
in the database, these 7 strains represent 1.34% of all SIT37/T3 strains present in SITVIT2. Fi-
nally, if we look for all identical strains in the database, we see that 19.19% were reported from
AFRI-E, 11.9% from EURO-N, 11.52% from EURO-W, etc. Finally, we have also added a new
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map (S3 Fig.) to show the global distribution of lineages in USA, Canada, and various Latin
American and Caribbean countries as compared to Chile.
In conclusion, we have shown the predominance of LAM and T genotypes corresponding
to almost two thirds of circulating stains for the central area of Santiago, Chile, in the study pe-
riod. We have also underlined the significant presence of SIT37/T3 among Chilean isolates.
This high proportion of SIT37/T3 in our study in Chile as well as in other countries of Latin
America (Guyana, Cuba, or Dominican Republic) in conjunction with East Africa, and to a
lesser extent in other regions and countries—including not negligible proportions in Nepal and
China—suggests long-lasting spread of this genotype. Obviously, more data and analysis are
needed to clarify probable ancestral human migrations responsible for its actual distribution
pattern. Further studies on a larger number of isolates and from patients with larger geographic
and ethnic diversity might help to accurately estimate the genetic landscape of prevailingM. tu-
berculosis epidemic in Chile.
Supporting Information
S1 Fig. Unweighted Pair Group Method with Arithmetic Mean (UPGMA) tree based on the
combination of spoligotypes and 12-loci MIRUs (using MLVA Compare software). Labels
identifying all strains are as follows: strain number, lineage, SIT, 12-MIT.
(TIF)
S2 Fig. Geographical maps (obtained by interrogating SITVIT2 database prior to entry of
this study) representing percentage distributions of strains belonging to SIT37 (A), and
strains belonging to T3 sub-lineage (B).Maps were reproduced from work created and
shared by Google (https://google-developers.appspot.com/site-policies) and used according to
terms described in the Creative Commons 3.0 Attribution License (http://creativecommons.
org/licenses/by/3.0/).
(TIF)
S3 Fig. Geographic distribution of lineages in Latin American and neighboring countries.
Note that the map file was downloaded under Creative Commons License using the link:
http://en.wikipedia.org/wiki/Latin_America and was manually modified for representative
purposes only.
(TIF)
S1 Table. Description of spoligotypes and MIRU12 patterns corresponding to orphans
strains (n = 16) in the SITVIT2 database.
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S2 Table. Description of spoligotypes, MIRU12 patterns and lineage allocation by SITVIT2
and MIRU-VNTRplus for all the isolates of present study (n = 103).
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S1 Fig. Unweighted Pair Group Method with Arithmetic Mean (UPGMA) tree based on the combination of spoligotypes and 12-
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Larger TIF image available online at: 
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IsoNumber Spoligotype Description Octal code Sublineage Lineage SIT MIRU12 12-MIT 
CHL022008000001  763357777560771 T1 T Or01 223425133322 340 
CHL022010300013  732457667560771 T1 T Or02 224326133324 313 
CHL022011000019  763777777560771 T1 T Or03 224225143224 Or29 
CHL022011000022  767777667760771 T1 T Or04 124326153220 190 
CHL022011000035  763377347760471 T4-CEU1 T Or05 223325173333 721 
CHL022013300048  676773777777631 Unknown Unknown Or06 222324253322 5 
CHL022012000059  776577607760771 LAM9 LAM Or07 224326133324 313 
CHL022012100062  764077767777771 Unknown Unknown Or08 232224253322 309 
CHL022012100069  777377775760771 T1 T Or09 223425143324 1675 
CHL022012000070  777377607560771 LAM6 LAM Or10 122326153226 Or30 
CHL022012100071  664077777777771 Unknown Unknown Or11 232224243322 990 
CHL022012100072  764077777777671 AFRI AFRI Or12 232224243322 990 
CHL022013100085  777777775120771 H3 H Or13 225326153323 247 
CHL022013000090  740136777760771 X1 X Or14 224426143322 Or31 
CHL022013000097  777764003560771 T1 T Or15 124226153222 179 
CHL022013000103  664077777747600 BOV BOV Or16 232224263322 48 
Supplemental Table S2. Description of spoligotypes, MIRU12 patterns and lineage allocation by SITVIT2 and 
MIRU-VNTRplus for all the isolates of present study (n = 103).
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S2 Table. Original PDF version available online at: 
http://journals.plos.org/plosone/article/asset?unique&id=info:doi/10.1371/journal.pone.0118007.s005  
